Down-regulation of aldose reductase renders J774A.1 cells more susceptible to acrolein- or hydrogen peroxide-induced cell death

References

• Andersen JK. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004; 10(Suppl): S18–S25
   Google Scholar
• Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17: 1195–1214
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler. Thromb Vasc Biol 2005; 25: 29–38
   PubMed Web of Science ®Google Scholar
• Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790–796
   PubMed Web of Science ®Google Scholar
• Kehrer JP, Biswal SS. The molecular effects of acrolein. Toxicol Sci 2000; 57: 6–15
   PubMed Web of Science ®Google Scholar
• Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003; 42: 318–343
   PubMed Web of Science ®Google Scholar
• Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 1998; 273: 16058–16066
   PubMed Web of Science ®Google Scholar
• Sierra LM, Barros AR, Garcia M, Ferreiro JA, Comendador MA. Acrolein genotoxicity in Drosphila melanogaster: I. Somatic and germinal mutagenesis under proficient repair conditions. Mutat Res 1991; 260: 247–256
   PubMed Web of Science ®Google Scholar
• Rudra PK, Krokan HE. Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive- and resistant human tumor cells. Anticancer Res 1999; 19: 461–469
   PubMed Web of Science ®Google Scholar
• Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 1991; 42: 781–795
   PubMed Web of Science ®Google Scholar
• Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 2002; 61: 1184–1191
   PubMed Web of Science ®Google Scholar
• Kang ES, Woo IS, Kim HJ, Eun SY, Paek KS, Kim HJ, Chang KC, Lee JH, Lee HT, Kim JH, Nishinaka T, Yabe-Nishimura C, Seo HG. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic Biol Med 2007; 43: 535–545
   PubMed Web of Science ®Google Scholar
• Keightley JA, Shang L, Kinter M. Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. Mol Cell Proteomics 2004; 3: 167–175
   PubMed Web of Science ®Google Scholar
• Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1999; 103: 1007–1013
   PubMed Web of Science ®Google Scholar
• Seo HG, Nishinaka T, Yabe-Nishimura C. Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: A potential role for aldose reductase in vascular remodeling. Mol Pharmacol 2000; 57: 709–717
   PubMed Web of Science ®Google Scholar
• Spycher SE, Tabataba-Vakili S, O'Donnell VB, Palomba L, Azzi A. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J 1997; 11: 181–188
   PubMed Web of Science ®Google Scholar
• Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 1992; 267: 4364–4369
   PubMed Web of Science ®Google Scholar
• Kolb NS, Hunsker LA, Vander Jagt DL. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. Mol Pharmacol 1994; 45: 797–801
   PubMed Web of Science ®Google Scholar
• Vander Jagt DL, Kolb NS, Vander Jagt TJ, Chino J, Martinez FJ, Hunsaker LA, Royer RE. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta 1995; 1249: 117–126
   PubMed Web of Science ®Google Scholar
• Nishinaka T, Yabe-Nishimura C. EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic Biol Med 2001; 31: 205–216
   PubMed Web of Science ®Google Scholar
• Fadeel B, Kagan VE. Apoptosis and macrophage clearance of neutrophils: regulation by reactive oxygen species. Redox Rep 2003; 8: 143–150
   PubMed Web of Science ®Google Scholar
• Hirvonen MR, Brüne B, Lapetina EG. Heat shock proteins and macrophage resistance to the toxic effects of nitric oxide. Biochem J 1996; 315: 845–849
   PubMed Web of Science ®Google Scholar
• Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JMC. The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)–iron(III) complex. Biochemical J 1989; 258: 617–620
   PubMed Web of Science ®Google Scholar
• Takahashi M, Fujii J, Miyoshi E, Hoshi A, Taniguchi N. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int J Cancer 1995; 62: 749–754
   PubMed Web of Science ®Google Scholar
• Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000; 5: 415–418
   PubMed Web of Science ®Google Scholar
• Tanel A, Averill-Bates DA. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta. 2005; 1743: 255–267
   PubMed Web of Science ®Google Scholar
• Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489
   PubMed Web of Science ®Google Scholar
• Monteil C, Le Prieur E, Buisson S, Morin JP, Guerbet M, Jouany JM. Acrolein toxicity: comparative in vitro study with lung slices and pneumocytes type II cell line from rats. Toxicology 1999; 133: 129–138
   PubMed Web of Science ®Google Scholar
• Nardini M, Finkelstein EI, Reddy S, Valacchi G, Traber M, Cross CE, Van der Vliet A. Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 2002; 170: 173–185
   PubMed Web of Science ®Google Scholar
• Luo J, Robinson JP, Shi R. Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem Int 2005; 47: 449–457
   PubMed Web of Science ®Google Scholar
• Ramana KV, Reddy AB, Tammali R, Srivastava SK. Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages. Free Radic Biol Med 2007; 42: 1290–1302
   PubMed Web of Science ®Google Scholar
• Voisin C, Aerts C, Wallaert B. Prevention of in vitro oxidant-mediated alveolar macrophage injury by cellular glutathione and precursors. Bull Eur Physiopathol Respir 1987; 23: 309–313
   PubMedGoogle Scholar
• Aerts C, Wallaert B, Gosset P, Voisin C. Relationship between oxygen-induced alveolar macrophage injury and cell antioxidant defence. J Appl Toxicol 1995; 15: 53–58
   Google Scholar